Godoy, Lucas C.; Neal, Matthew D.; Goligher, Ewan C.; Cushman, Mary; Houston, Brett L.; Bradbury, Charlotte A.; McQuilten, Zoe K.; Tritschler, Tobias; Kahn, Susan R.; Berry, Lindsay R.; Lorenzi, Elizabeth; Jensen, Tom; Higgins, Alisa M.; Kornblith, Lucy Z.; Berger, Jeffrey S.; Gong, Michelle N.; Paul, Jonathan D.; Castellucci, Lana A.; Le Gal, Grégoire; Lother, Sylvain A.; Rosenson, Robert S.; Derde, Lennie P.G.; Kumar, Anand; McVerry, Bryan J.; Nicolau, Jose C.; Leifer, Eric; Escobedo, Jorge; Huang, David T.; Reynolds, Harmony R.; Carrier, Marc; Kim, Keri S.; Hunt, Beverley J.; Slutsky, Arthur S.; Turgeon, Alexis F.; Webb, Steven A.; McArthur, Colin J.; Farkouh, Michael E.; Hochman, Judith S.; Zarychanski, Ryan; Lawler, Patrick R.
(Elsevier, 2024-03)
Background: Clinical trials suggest that therapeutic-dose heparin may prevent critical illness and vascular complications due to COVID-19, but knowledge gaps exist regarding the efficacy of therapeutic heparin including ...